News and stories

New processing technology could help companies produce the next generation of high-value marine products, while keeping the entire value chain in New Zealand

A live probiotic skincare ingredient that remains stable without refrigeration now sits on shelves at Harrods. Getting there required solving some serious fermentation and formulation challenges.

At a glace Pharmalink Extracts collaborated with the Biotechnologies Group when they needed advanced extraction capability to unlock high-value marine oils.

The Biotechnologies Group now has regulatory approval to process marine products for human and animal consumption.

Callaghan Innovation has announced the resignation of its Chief Executive, Stefan Korn.

At a glance Premium Seas collaborated with Callaghan Innovation’s Biotechnologies Group to develop and scale a process for concentrating and drying a fucoidan-rich seaweed extract.

At a glance Alchemy Gisborne partnered with Callaghan Innovation to transform the way finger limes are processed and create new value from second-grade fruit.

Callaghan Innovation has engaged KPMG to assist it to explore commercial options for the future of its science facilities at Gracefield in Lower Hutt.

At a glance Ārepa, a brain-food technology company, is developing a novel sarmentosin isolate from blackcurrant by-products.

At a glance Alpha Group partnered with the Biotechnologies Group to develop a novel submerged fermentation process for Ganoderma lingzhi (Reishi mushroom).

At a glance Hawke’s Bay-based Kabocha Innovation is transforming squash seed by-product into a high-protein powder for use in beverages, bars, and more.

Dr Kirill Lagutin, Dr Andrew Lewis and Thomas Austin from our Biotechnologies Group have put local oils to the test, comparing the quality and composition of NZ extra virgin olive oils to international offerings as part of a recent market surveillance study.